Open Text (OTEX)
(Delayed Data from NSDQ)
$31.50 USD
+0.35 (1.12%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $31.70 +0.20 (0.63%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Price, Consensus and EPS Surprise
OTEX 31.50 +0.35(1.12%)
Will OTEX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for OTEX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OTEX
Is the Options Market Predicting a Spike in Open Text (OTEX) Stock?
OpenText (OTEX) Acquires Pillr to Boost Cybersecurity Offerings
OTEX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Open Text (OTEX) Q3 Earnings Meet Estimates
Open Text (OTEX) Reports Next Week: Wall Street Expects Earnings Growth
OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for OTEX
ClearBridge Canadian Dividend Strategy Q2 2024 Commentary
Export Development Bank of Egypt Transforms Traditional Banking with OpenText
Open Text (OTEX) Gets a Hold from CIBC
OpenText price target lowered by $3 at CIBC, here's why
OpenText Faces Slow Organic Revenue Growth And Higher R&D Expenses